medical cannabis
CALGARY, AB, Aug. 30, 2023 /PRNewswire/ – Decibel Cannabis Company Inc. (the “Company” or “Decibel”) (TSXV: DB) (OTCQB: DBCCF), a market leader in premium cannabis and extract manufactured products, is pleased to announce that it has expanded its global footprint by entering into a supply agreement (the “Agreement”) to provide premium dried medical cannabis flower to 4C LABS, a […]
Fort Lauderdale, Florida–(Newsfile Corp. – June 27, 2023) – Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a consumer-packaged goods leader serving all 50 states with 15,000+ points of distribution around the world and a pharmaceutical distributor in 28 countries, announced today that Clifford Starke has been appointed as Chief Executive Officer to lead […]
BZAM Ltd. & 4C LABS conclude strategic distribution agreement for the UK market
VANCOUVER, BC, TORONTO and LONDON, May 23, 2023 /PRNewswire/ – BZAM Ltd. (the “Company” or “BZAM“) (CSE: BZAM) (US-OTC: BZAMF), is pleased to announce that its subsidiary, The Green Organic Dutchman Ltd. (collectively the “Company”) has entered into a strategic distribution agreement with 4C LABS Ltd. (“4C LABS”), a London, UK based import & distribution company focused on the medical cannabis space. The Company […]
Leva Clinic has secured $3.5m USD (£3m GBP) of funding from Óskare Capital and Justin Hartfield to accelerate innovation in medical cannabis therapeutics and scale the delivery of digital solutions for chronic pain patients. Leva Clinic has announced that it has secured $3.5m USD (£3m GBP) of funding from Óskare Capital and Justin Hartfield […]
Akanda prepares first export shipment to Germany of high THC indoor cultivated premium cannabis from its Portugal-based Holigen operation in the coming weeks Akanda aims to capture approximately 10% market share German medical cannabis imports based on recent data LONDON–(BUSINESS WIRE)–International medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) expects […]
The new and improved products are derived from novel proprietary cannabis varieties developed using genetic markers utilizing Evogene’s GeneRator AI tech-engine REHOVOT, Israel, Sept. 21, 2022 /PRNewswire/ — Canonic Ltd., focused on the development of medical grade cannabis products and a wholly owned subsidiary of Evogene Ltd. ( Nasdaq: EVGN, TASE: EVGN), today announced the launch of its second-generation products in Israel. […]
Akanda Bolsters Leadership Team to Scale Medical Cannabis Platform Across Europe
Tom Flow Named Chief Operating Officer and Steven George Named Commercial Director LONDON, August 24, 2022–(BUSINESS WIRE)–International medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today announced that it has appointed Tom Flow to the role of Chief Operating Officer of Akanda and Managing Director of Holigen, and Steven George […]
Acquisition provides Khiron with an EU-GMP European manufacturing and distribution hub for medical cannabis and other pharmaceutical products The acquisition of Pharmadrug Production GmbH provides Khiron with direct access to German pharmacies and increase in gross margins for its products With acquisition completed, Khiron will continue sales of its current products and expand its portfolio, […]
HEMP BioSciences Inc., a wholly-owned Division of WEED Inc will oversee our Genetics Programs. Panama Red, Acapulco Gold, Red Bud Colombian & Santa Marta Gold top the list. TUCSON, AZ / ACCESSWIRE / July 20, 2022 / WEED, Inc. (OTCQB:BUDZ) (“WEED” or the “Company”) a global cannabis & hemp bioresearch company based in the USA, […]
Texas Original Opens Drive-Thru Medical Cannabis Pickup Location in Waco, Texas
AUSTIN, Texas, June 28, 2022–(BUSINESS WIRE)–Texas Original, Texas’ leading medical cannabis provider, announced its newest prescription pickup location has opened in Waco, Texas. The new location is Waco’s first medical cannabis pickup site and the first drive-thru location in the state. The pickup location is open every Friday between 10:30 a.m. and 2 p.m. for […]
LONDON–(BUSINESS WIRE)-June 28, 2022-Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN), an international medical cannabis platform company, today announced that its UK import and distribution wholly-owned subsidiary CanMart Ltd. (“CanMart”) has partnered with Phlo Connect and Cellen Life Sciences (“Cellen”) to create a first-of-its-kind fully digital dispensing collaboration for medical cannabis. The strategic partnership strengthens […]
Khiron Life Sciences Reports 2021 Fiscal Year End Results
2021 total revenue increased over 60% YoY to $12.8 million compared to the previous year Corporation’s medical cannabis sales in 2021 increased to $4.6 million, representing 36% of total revenue The Corporation forecasts Q1 2022 sales revenue of ~ $4.5 million for the quarter Gross profit increased over 230% YoY to $4.9 million, driven by the continuous growth of the highly […]
Transformational deal will add prized cultivation, manufacturing and distribution assets to accelerate Akanda’s seed-to-patient model and satisfy demand in fast-growing European cannabis markets Akanda will have immediate EU GMP certification, a significantly expanded product portfolio, and an award-winning genetics library LONDON–(BUSINESS WIRE)–International medical cannabis company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today […]
Global Medical Cannabis Leader Khiron Opens New Zerenia™ Clinic and Retail Pharmacy in Colombia
Continues market leadership in Colombia, Latin America’s only country with universal health coverage for medical cannabis Market leader in the Colombian medical cannabis market, with Q1 2022 volume sales exceeding 21,400 units, up 280% YoY and more than 40% of all 2021 New clinic continues Khiron’s unique patient acquisition and retention strategy, adding more than 20% of patient capacity to existing network Located in […]
Unity Rd. Partners Awarded Medical Cannabis Establishment Registration Certificate in South Dakota
Local Partners Kick Off Development with Groundbreaking for One of the First Establishments in Hartford; Cannabis Dispensary Franchise Now Developing in 10-Plus U.S. Markets SIOUX FALLS, S.D., April 11, 2022 /PRNewswire/ — Unity Rd., the national cannabis dispensary franchise from Item 9 Labs Corp. (OTCQX: INLB), announced today that the brand’s first partners in South Dakota have received approval from Hartford, a suburb […]
The combined companies will showcase strong leadership teams, a portfolio of powerful brands and operations delivering quality at scale The new combined company will utilize multiple markets, retail locations, technologies and distribution facilities, paired with solid backing and options to operate in numerous countries LOS ANGELES and KINGSTON, Jamaica, April 05, 2022 (GLOBE […]
Franchise Global Health Inc. Announces First Day of Trading & Market Opening
VANCOUVER, BC / ACCESSWIRE / March 29, 2022 / Franchise Global Health Inc. (“Franchise Global” or the “Company”) (TSXV: FGH) is pleased to announce that the Company’s shares will commence trading at market open today on the TSX Venture Exchange under the symbol “FGH”. In addition, Clifford Starke, Executive Chairman and CEO of Franchise Global and his team […]
AUDACIOUS is the first US Multi-State Operator to open a cannabis clinic in Thailand in partnership with Thai-based Golden Triangle Health. LAS VEGAS, March 21, 2022 /PRNewswire/ – Just as the dynamic Thai medical cannabis market begins to blossom, AUDACIOUS and Thai-based partner Golden Triangle Health have partnered to open the first Herbidus Medical Center in Bangkok, which is also the first medical […]
UCASU to partner with seasoned cannabis growers for $50 million cannabis portfolio
Atlanta, March 21, 2022 (GLOBE NEWSWIRE) — UC Asset LP (OTCQX: UCASU) announces the company is launching a program to form investor-grower partnerships with seasoned cannabis growers, who are licensed in their own states to grow hemp, medical cannabis or recreational cannabis plants, to work on UC Asset’s cannabis portfolio properties that are expected to […]
IM Cannabis Reports Record Preliminary Fourth Quarter and Full Year 2021 Financial Results
Q4 2021 revenues expected to be at least $20 million, an increase of at least 308% year-over-year and at least 37% sequentially Full Year 2021 revenues expected to increase at least 240% year-over-year to at least $54 million TORONTO and GLIL YAM, Israel, March 10, 2022 /PRNewswire/ — IM Cannabis Corp. (the “Company“, “IM Cannabis“, or “IMC”) (CSE: IMCC) (NASDAQ: IMCC), […]
Village Farms International Announces Pure Sunfarms’ Receipt of EU GMP Certification
– EU GMP Certification Permits Pure Sunfarms to Export Cannabis Products to EU Medical Markets – First Shipments Targeted for Third Quarter 2022 – VANCOUVER, BC, March 9, 2022 /PRNewswire/ – Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) today announced its wholly owned subsidiary, Pure Sunfarms, has received EU GMP certification from Bezirksregierung […]
Curaleaf Expands Pennsylvania Retail Presence with Dispensary Openings in State College and Erie
Newest Dispensaries Expand Company’s Retail Presence to 16 Locations in Fast Growing Pennsylvania Medical Market, and 127 Nationwide WAKEFIELD, Mass., Feb. 18, 2022 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer products in cannabis, today announced the opening of its State College dispensary, located at 1248 S Atherton […]
Khiron Adds Another Clinic Location in Peru
Khiron partners with specialized pain clinic, Clínica del Dolor Lima (“CDL”) to provide medical cannabis treatment access to its over 10,000 chronic pain patient population TORONTO, Feb. 17, 2022 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a global medical cannabis leader with core operations in Latin America and Europe, is pleased to […]
FRANKFURT, Germany & HYDERABAD, India, February 03, 2022–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced that it has entered into a definitive agreement to acquire Nimbus Health GmbH (“Nimbus Health”). Nimbus Health is a privately owned, licensed pharmaceutical […]
RYAH Closes Initial Tranche of Private Placement Units
TORONTO, ON / ACCESSWIRE / January 27, 2022 / RYAH Group, Inc. (CSE:RYAH) (“RYAH” or the “Company“) is pleased to provide an update to its previously announced non-brokered private placement of units of the Company (“Units“) for aggregate gross proceeds of up to C$1,500,000, at an issue price of C$0.05 per Unit (the “Private Placement“). As […]
Panaxia and Neuraxpharm: First export of medical cannabis sublingual tablets to France
The first-of-its-kind export is part of the companies’ participation in the French government’s program to regulate the medical cannabis industry Both companies have previously issued their premium oils to patients in France DÜSSELDORF, Germany and TEL AVIV, Israel, Jan. 24, 2022 /PRNewswire/ — Panaxia Labs Israel Ltd. (“Panaxia Israel”), (TASE: PNAX), a global pharma company which develops, manufactures and markets […]
OTC Markets Group Welcomes Mystic Holdings Inc. to OTCQX
NEW YORK, Jan. 21, 2022 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for over 11,000 U.S. and global securities, today announced Mystic Holdings Inc. (OTCQX: MSTH), a company focused on cannabis cultivation, production and retail, has qualified to trade on the OTCQX® Best Market. Mystic Holdings Inc. upgraded to OTCQX from the Pink® […]
JERUSALEM, ISRAEL… January 14, 2022 — The Hebrew University of Jerusalem’s (HU) Technology Transfer Company, Yissum, together with the TechforCann Europe Accelerator, announces a strategic collaboration with TechforCann, Europe’s first medical cannabis tech accelerator, to fund startups around the world. Researchers at HU’s Multidisciplinary Center for Cannabinoid Research, (MCCR) will serve as advisory board members, mentors, and potential candidates for the startups that are accepted into the TechforCann Europe Accelerator program. The HU Medical Cannabis online curriculum will also be available to international audiences through the […]
Stem Holdings Reports Fiscal Full Year 2021 Financial Results
BOCA RATON, Fla., Jan. 13, 2022 (GLOBE NEWSWIRE) — Stem Holdings, Inc. (OTCQX: STMH) (CSE: STEM) (the “Company” or “Stem”), a vertically integrated cannabis operator, today reported its financial results for the fiscal year ended September 30, 2021. All amounts are expressed in U.S. dollars unless indicated otherwise and are prepared under International Financial Reporting Standards […]
Regina, Saskatchewan – TheNewswire – January 7, 2022 – HTC Purenergy Inc. o/a HTC Extraction Systems (“HTC” or the “Company”) (TSXV:HTC), (OTCQB:HTPRF), (UII:FRA) today announced that further to its news release dated December 31, 2021, it has applied for approval from the TSX Venture Exchange (the “TSXV”) of its sale (the “Transaction”) of certain of its assets used in its California-based […]
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Alan Brochstein’s 420 Investor is the go-to community for investors to learn, explore, and profit from the marijuana companies. The main goal of 420 Investor is to provide real-time, objective information about the top marijuana companies in the market in order to help investors capitalize on cannabis.
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
Founded in the spring of 2014, Genius Extraction is owned and operated by its creators, Robert and Brenna Gaither. While Robert brings his sales prowess to the endeavor, Brenna’s strong background, education, and training in biochemistry establish the foundation for the company’s credibility in the extraction industry. With a strong understanding of the extraction industry’s […]
Relevium is a publicly-traded company that operates in the health and wellness industry, including legal cannabis, with a primary focus on online distribution.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
